Get started
Author

Joachim Chan

Observed names: J Chan, J. Chan
ORCID: 0009-0008-1779-9142
Observed ORCID: 0009-0008-1779-9142
OpenAlex ID: A5110064569
Bladder-Sparing Treatment With Radical Dose Radiotherapy Is an Effective Alternative to Radical Cystectomy in Patients With Clinically Node-Positive Nonmetastatic Bladder Cancer
2023 · Martin Swinton, Neethu Billy Graham Mariam, et al. · Journal of Clinical Oncology · 57
Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres
2020 · Joachim Chan, Helen Adderley, et al. · European Journal of Cancer Care · 50
PDF
P5-18-05: Incidence of Febrile Neutropenia in Patients Treated with Docetaxel and Cyclophosphamide (TC) for Adjuvant Breast Cancer.
2011 · J Yee, J Chan, et al. · Cancer Research · 6
Permanent Hair Loss Associated with Taxane Chemotherapy Use in Breast Cancer: a Retrospective Review at Two Tertiary UK Cancer Centres
2020 · H. Adderley, J. Chan, et al. · Clinical Oncology · 2
Avelumab first-line (1L) maintenance therapy for advanced urothelial cancer: real-world early clinical experience in the UK
2023 · R.J. Jones, Y. Shah, et al. · European Urology Open Science · 1
Real-Life Outcomes of First-Line Palliative Chemoimmunotherapy in Oesophago-Gastric Cancers: A Multi-Centre Retrospective Cohort Study
2026 · James Birch-Ford, Ben Crosby, et al. · Cancers
PDF
Systemic Immunotherapy
2026 · Joachim Chan, Syed Owais Bokhari · Springer eBooks
Systemic Chemotherapy
2026 · Syed Owais Bokhari, Joachim Chan · Springer eBooks
AURORA: A single arm, multicentre, phase II clinical trial of atezolizumab immunotherapy for advanced squamous cell carcinoma of the bladder and urinary tract.
2025 · Simon J. Crabb, Jonathan Martin, et al. · Journal of Clinical Oncology
PDF
Works count: 9
Citation count: 116
H-index: 3
I10-index: 2
Year
Topic
Type